Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Rare Earth Play MCP Upgraded! price target of $80
Molycorp (MCP)is initiated with an Outperform at CIBC World Markets, which sets a price target of $80. Stock has added 4% in pre-market already.
http://finance.yahoo.com/news/Wall-to-Wall-Street-Coverage-minyanville-3517658636.html?x=0&.v=1
MCP Upgraded! price target of $80
Molycorp (MCP): MCP is initiated with an Outperform at CIBC World Markets, which sets a price target of $80.
http://finance.yahoo.com/news/Wall-to-Wall-Street-Coverage-minyanville-3517658636.html?x=0&.v=1
MCP Upgraded! price target of $80
Molycorp (MCP): MCP is initiated with an Outperform at CIBC World Markets, which sets a price target of $80.
http://finance.yahoo.com/news/Wall-to-Wall-Street-Coverage-minyanville-3517658636.html?x=0&.v=1
Lynas’s Nick Curtis Builds Fortune With Bet on Rare Earths
http://www.bloomberg.com/news/2011-03-07/lynas-s-nick-curtis-builds-fortune-with-bet-on-rare-earths.html?cmpid=yhoo
If it had been an up market day, the stock would have run, IMHO. I hope Monday is better.
Any guesses on what earnings day might hold in store on Wednesday?
Also, check this out:
http://seekingalpha.com/article/256502-technical-break-out-candidate-molycorp?source=yahoo
BPAX & AIS positive news this weekend should help both stocks!
http://finance.yahoo.com/news/BioSante-Pharmaceuticals-bw-381121180.html?x=0&.v=1
AIS is the better play here because BPAX has already run up so much, IMHO:
http://www.smartbrief.com/news/advamed/industryMW-detail.jsp?id=FE446928-D7F3-49BB-A322-2AC822650B62
BPAX & AIS positive news this weekend should help both stocks!
http://finance.yahoo.com/news/BioSante-Pharmaceuticals-bw-381121180.html?x=0&.v=1
AIS is the better play here because BPAX has already run up so much, IMHO:
http://www.smartbrief.com/news/advamed/industryMW-detail.jsp?id=FE446928-D7F3-49BB-A322-2AC822650B62
Very bullish RPC news article out!!!
http://www.smallcapnetwork.com/Radient-Pharmaceuticals-Bullish-or-Bullcrap/s/article/view/p/mid/5/id/160/
News: "Another short squeeze underway at RPC"
Read the article here. This could be significant.
http://www.smallcapnetwork.com/Another-short-squeeze-forming-at-Radient-Pharmaceuticals/s/article/view/p/mid/5/id/157/
News article: "Another short squeeze underway at RPC"
http://www.smallcapnetwork.com/Another-short-squeeze-forming-at-Radient-Pharmaceuticals/s/article/view/p/mid/5/id/157/
Radient Pharmaceuticals (Amex:RPC) upgraded to Buy. More news expected!
See the details at the link below. Could be setting up for a nice run.
http://www.tradingmarkets.com/news/press-release/rpc_radient-pharmaceuticals-amex-rpc-upgraded-from-a-hold-to-a-buy-after-cash-infusion-1460198.html
RPC just upgraded from Hold to Buy!
See the story below. More news expected!
http://www.tradingmarkets.com/news/press-release/rpc_radient-pharmaceuticals-amex-rpc-upgraded-from-a-hold-to-a-buy-after-cash-infusion-1460198.html
Pending partnership puts RPC shares at $4+
Article and details:
http://www.tradingmarkets.com/news/press-release/rpc_positive-news-flow-continues-for-radient-pharmaceuticals-nyse-amex-rpc--1434614.html
This is the latest, however...
http://biomedreports.com/2011011862508/keeping-my-fingers-crossed-for-regenicin.html
News out about RPC: "Affirmatory developments behind Radient's upsurge"
Good read with new information has just been released over the weekend.
http://www.benzinga.com/press-releases/11/01/c782520/affirmatory-developments-behind-radients-upsurge
RPC NEWS OUT! "Affirmatory developments behind Radient's upsurge"
Good read with new information just released this weekend...
http://www.benzinga.com/press-releases/11/01/c782520/affirmatory-developments-behind-radients-upsurge
Important to note! Another short squeeze is setting up here. Check it out...
http://regsho.com/tools/short_list.php?src=2,5
RPC set for another big day thanks to news
This is the key line in today's press release. I think it provides a major hint about how they feel the Mayo validation study is going and that is why shares are breaking out pre-market:
"RPC has been invited to present at various scientific and medical conferences, including the upcoming European Multidisciplinary Conference in Thoracic Oncology (EMCTO) international conference, 24-26 February 2011, where the Company will present an abstract under the title of "The Validation of Fibrin and Fibrinogen Degradation Products Assay for Early Detection of Lung Cancer."
This is the key line in today's press release. I think it provides a major hint about how they feel the validation study is going and that is why shares are breaking out pre-market:
"RPC has been invited to present at various scientific and medical conferences, including the upcoming European Multidisciplinary Conference in Thoracic Oncology (EMCTO) international conference, 24-26 February 2011, where the Company will present an abstract under the title of "The Validation of Fibrin and Fibrinogen Degradation Products Assay for Early Detection of Lung Cancer."
Where did you see that? Link?
Incredible volume coming into this thing.
I like Mr. Cousins. He's a good guy. I feel very bad for what is happening to his company. Oh and by the way.. Did you see RPC today? My "bold" prediction came true. Just trying to help out man. No hard feelings.
Take it to the bank. You'll see.
Plain and simple. If you look at history. Any time a "replacement" like this happens things do not turn out well for those companies.
John Cousins is about as honest as they come on Wall Street. He did not feel right being out in front of this messy situation and he stepped aside.
I'm placing my bet on the company that has the better, more expensive, fda approved product that is ready to go to market. Most all the risk is off the table at RPC.
Insurance companies may hate it, but doctors, labs and facilities always submit the more expensive tests for reimbursements. And as an investor I want the biggest return/potential return for my money.
It doesn't speak well that BMOD's test costs a lot less. Not in this case.
Look at the headlines and analysts. Who is talking about which company and what kind of price targets are they giving for each stock?
Your post is 100% on the money. The writing is on the wall here. RPC has a great deal going for it and anyone who is willing to exchange millions in debt for equity knows that something is up.
No fda approvals to wait for here. The product is going to market and it is ready make some big revenues.
The problem with Biomoda is that they are having internal issues (CEO just stepped down which is 90% a sign that the ship is going down) and they have delayed results of phase II trials.
We're also comparing apples to oranges when you compare BMOD to RPC.. RPC test is FDA approved and it can detect 14 different types of tumors. You get what you pay for.
Biomoda has no sales or income not even a distribution mechanism.
Much riskier bet.
Shares of RPC dropped after the trading was halted- almost always happens as the market fgoes into a panic.
RPC is a much more stable and now debt free company with real orders, revenue and huge pending developments and good news flow.
Guaranteed shares will go higher on Monday. Especially if the company releases news as expecting.
RPC trading has been halted! Good news expected!!!
RPC trading has been halted. Biomedreports just posted an item in the premium subscriber section. Anyone know what it says? I think it has something to do with RPC. This thing is gonna fly!
At this rate over a million shares of RPC are going to trade pre-market!
On top of that, this one is going to explode if the Amex announces approval of the debt-to-equity swap today.
When the Amex approval news hits today (that is expected today no?)the shorts are going to get hit smack in the face with a bull kick. They better start covering early!
Not only is it gonna rebound, it's gonna continue the uptrend.
RPC chart video for Thursday
Looks like more good developments and news ahead.
Upward and onward!
Latest technical analysis RPC video!
Looks like more good developments and news ahead. Upward and onward!
If so, why invest in a company that is set to make less money?
Agreed! This thing is a monster!